Inspection Record

Healix Infusion Therapy, Inc. — FDA 483 Findings

US FDAInspected 2015-07-10Published 2024-01-17 3 findingsTraining and personnelAseptic processing and sterility assurance

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Clothing of personnel engaged in the manufacturing and processing of drug products is not appropriate for t he duties they perform.

2Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

3Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Healix Infusion Therapy, Inc. company profile — full history US FDA documents, 2024 Go to Findings search